CBD Hacker Ranks the 20 Best CBD Oil Drops for 2019 [With Lab Results]

CBD Hacker’s team incorporated third-party lab analysis, hands-on evaluation, and company research to narrow down a list of dozens of brands and …
Photo of bottles of the top five CBD oils from CBD Hacker's 2019 CBD oil ranking

CBD Hacker ranks the 20 Best CBD Oil Drops for 2019

The most competitive CBD brands are working hard to demonstrate their quality and dependability.

BOARDMAN, Ohio (PRWEB)March 13, 2019

CBD Hacker, the definitive guide to the CBD industry, has updated their ranking of the top CBD oil brands with their revised and expanded list of the 20 Best CBD Oil Drops for 2019.

Each product received a score for five categories:

  • Product quality and value
  • User experience
  • Customer service
  • Reputation
  • Transparency and labeling accuracy

What’s new in this year’s updated ranking?

In the last year, many of the leading CBD brands have made significant changes. From taking control of the supply chain by growing their own hemp, to adopting more consumer-friendly guarantees and transparency practices, the trends reveal an industry that is vying to gain consumer confidence.

“In the CBD industry right now, it’s all about trust,” said Meg Kramer, CBD Hacker’s managing editor. “An increase in media coverage is increasing awareness about CBD. At the same time, it’s helping consumers to be more savvy about the potential risks in buying unregulated products. That means that the most competitive brands are working hard to demonstrate their quality and dependability.”

CBD Hacker’s team cast a wide net for this ranking, starting with a list of over 60 brands, and more than 30 products made it through the gantlet to be considered for the final list. The full ranking includes the following CBD companies:

  • 4 Corners Cannabis – Bayfield, Colorado
  • Bluebird Botanicals – Louisville, Colorado
  • CBDistillery – Denver, CO
  • Charlotte’s Web – Denver, CO
  • EsseCann – Valrico, FL
  • Fab – Tampa, FL
  • Green Gorilla – Malibu, CA
  • Head + Heal – Cortland, NY
  • Hoboken Hemp – Hoboken, NJ
  • Joy Organics – Fort Collins, Colorado
  • Lazarus Naturals – Seattle, WA
  • Mission Farms – Bend, OR
  • NuLeaf Naturals – Denver, CO
  • Oilly CBD – Algonquin, IL
  • PlusCBD Oil – San Diego, CA
  • Populum – Tempe, AZ
  • Press Pause Project – Denver, CO
  • Pure Kind Botanicals – Fort Lupton, CO
  • Pure Spectrum – Evergreen, CO
  • RE Botanicals – Denver, CO

In addition, the ranking highlights companies that performed exceptionally well in specific categories, such as the best organic, full-spectrum, and THC-free CBD products.

About CBD Hacker:

CBD Hacker’s mission is to introduce transparency into an unregulated and confusing industry. With cannabidiol’s growing popularity, the CBD industry is experiencing rapid growth—but it has little to no oversight. CBD Hacker uses evidence-based reporting, third-party lab testing and blind product-testing methodology to dispel misinformation and help consumers to know what they are buying.

Related Posts:

  • No Related Posts

Cannabis maker Aurora picks billionaire investor Nelson Peltz as adviser

(Reuters) – Canada’s Aurora Cannabis Inc named billionaire investor … The appointment comes weeks after rival Canopy Growth Corp appointed …

(Reuters) – Canada’s Aurora Cannabis Inc named billionaire investor Nelson Peltz as a strategic adviser on Wednesday, sending the company’s U.S.-listed shares up 11 percent in trading before the bell.

FILE PHOTO: The Logo for Aurora Cannabis Inc., a Canadian licensed cannabis producer, is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, U.S., January 8, 2019. REUTERS/Brendan McDermid

The company has offered Peltz an option to buy about 20 million of its shares at C$10.34 a share, a small discount on the stock’s close of C$10.64 on Tuesday.

The stock option will vest ratably over a four-year period on a quarterly basis, Aurora said.

Aurora will tap into Peltz’s extensive experience in the consumer industry and work with him to explore potential partnerships that will expand the company globally.

“We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact,” said Aurora CEO Terry Booth in a statement.

The appointment comes weeks after rival Canopy Growth Corp appointed lifestyle guru Martha Stewart to help develop and launch a line of pot-based products.

Cannabis firms are also looking beyond recreational marijuana to drive sales, and the passing of the U.S. farm bill last year has opened the door for hemp, a cannabis plant with no or extremely low concentrations of “high” inducing THC.

Hemp can be used in foods, organic body care and clothing, among others.

Cannabis companies in Canada have been pouring cash into their businesses to fend off competition as well as develop new products, after the country approved the use of recreational marijuana in October.

“Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry,” said Peltz in a statement.

Peltz, who heads investment management firm Trian Fund Management, has waged battles against several consumer conglomerates, including a push for the separation of Kraft into Mondelez International and Kraft Foods Group in 2012. He won a board seat in Procter & Gamble Co in 2017 after waging what was the largest proxy fight ever.

Reporting by John Benny in Bengaluru; Editing by Shinjini Ganguli

Related Posts:

  • No Related Posts

Better Buy: Canopy Growth (TSX:WEED) or Aurora Cannabis (TSX:ACB)?

Let’s take a deeper look at Aurora Cannabis (TSX:ACB)(NYSE:ACB) and Canopy Growth Corp. (TSX:WEED) (NYSE:CGC) — the two biggest …

For investors, it’s really tough to know when a stock has reached its peak and when it’s bottomed out. For that same reason, it’s not easy to pick a marijuana stock when some players are doing so well and others are lagging behind.

But if you have a long-term perspective, this decision becomes much easier. Let’s take a deeper look at Aurora Cannabis(TSX:ACB)(NYSE:ACB) and Canopy Growth Corp.(TSX:WEED) (NYSE:CGC) — the two biggest marijuana stocks — to analyze their business potential and long-term value.

Canopy Growth

Canopy Growth is one of the few weed stocks with a solid foundation to grow its business and reward investors in the long run.

Canopy’s market size, capacity to ramp up production and diversity of product offerings make it a much stronger player. The company currently operates weed-growing facilities with over 2.4 million square feet of space.

But the producer has been expanding its operations quickly, which will deliver the potential to manage more than five million square feet of production space by next year. In the latest development, Canopy Growth acquired a hemp licence in New York State, as it plans to build an extraction and manufacturing facility.

One of the largest alcoholic beverage giants, Constellation Brands, last year raised its stake in the company to USD$4 billion, acquiring a nearly 40% stake in Canopy. Helped by these positive developments, Canopy Growth has surged more than 60% this year, outperforming its peers massively.

Aurora Cannabis

Aurora Cannabis has been in the headlines during the past one year due to its massive deal activity. The company bought MedReleaf Corp. and CanniMed Therapeutics last year, consolidating Aurora’s market position in the medical segment.

Aurora operates in 21 countries with a strong presence in the European Union. It expects its global medical cannabis business to accelerate significantly in the coming years. Aurora shares jumped more than 7% today after the company announced that billionaire investor Nelson Peltz is joining the company as a strategic adviser.

Peltz, whose New York-based Trian Fund Management LP has more than $10 billion under management, will advise Aurora on “potential partnerships with leading corporations,” the company said in a statement today.

“Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many verticals of great interest to us,” Aurora Chief Executive Officer Terry Booth said in the statement.

Bottom line

Both Canopy and Aurora are two top pot stocks that you can consider to keep in your portfolio. No doubt Canopy has had a very powerful rally in 2019 after posting 60% gains, but I still believe there is a further upside if the company continues on its growth path.

Aurora, on the other hand, has a much bigger short-term upside potential as the company looks for a strategic partnership with a top consumer brand. You can divide your investment equally between these two names to hedge your bets.

Have you heard about Amazon’s secretive “Project Vesta”?

Few people have… yet some of the greatest minds in the world believe this innovative technology could change the world.

Amazon doesn’t want anyone to know about this top-secret project, but there’s something even Amazon doesn’t know…

One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.

But you’ll need to hurry if you want to pick up this TSX stock before its name is on everyone’s lips.

To learn more about this exciting technology and dark horse TSX stock before it’s too late, click here now.

Related Posts:

  • No Related Posts

Aurora Cannabis Spikes After Billionaire Activist Nelson Peltz Added as Adviser

Rival Canopy Growth Corp. (CGC – Get Report) was also on the move following the Peltz addition, with shares rising 1.3% in pre-market trading to …

Aurora Cannabis Inc. (ACB) shares were marked sharply higher Wednesday after it named billionaire activist investor Nelson Peltz as a strategic adviser to the Canada-based group.

Peltz will advise the group on its global acquisition strategy and potential business partnership, Aurora Cannabis said, and will be granted options to purchase around 20% of the company’s shares at C$10.34 each ($7.74).

“Nelson is a globally recognized business visionary with a strong track record of constructive engagement to generate accelerated, profitable growth and shareholder value across many industry verticals that are of great interest to us,” said CEO Terry Booth. “Like us, Nelson also takes a long-term view of value creation to benefit all stakeholders. We look forward to working with Nelson to further extend our global cannabis industry leadership by aligning Aurora with each of the major market segments cannabis is set to impact.”

Aurora Cannabis shares were marked 10.5% higher at the opening bell Wednesday to change hands at $8.81 each, a move that would extend the stock’s year-to-date advance to around 68%.

Rival Canopy Growth Corp. (CGC) was also on the move following the Peltz addition, with shares rising 1.9% to change hands at $47.66 each. Cronos Group Inc. (CRON) , jumped 1.8% $21.75 each.

“I believe Aurora has a solid execution track record, is strongly differentiated from its peers, has achieved integration throughout the value chain and is poised to go to the next level across a range of industry verticals,” Peltz said. “I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve, with a strong, globally replicable operating model.”

Last month, Aurora Cannabis posted a wider-than-expected fiscal second-quarter loss of C$237.8 million but said it sold 6,999 kg of cannabis over the three month period, helping revenues rise to C$54.2 million.

Related Posts:

  • No Related Posts

Quebec cannabis giant HEXO acquires Newstrike Brands in $260-million deal

Quebec cannabis giant HEXO Corp. is acquiring Newstrike Brands Ltd. … the top two players — Aurora Cannabis Inc. and Canopy Growth Corp.

Quebec cannabis giant HEXO Corp. is acquiring Newstrike Brands Ltd. — the Oakville-based mid-sized cannabis company backed by The Tragically Hip — in an all-stock deal worth $260 million, both companies announced early Wednesday morning.

The deal is the biggest yet to take place between two sizeable Canadian cannabis companies post-legalization in a crowded industry where the top two players — Aurora Cannabis Inc. and Canopy Growth Corp. — control just under 50 per cent of domestic recreational cannabis sales.

HEXO currently has a market value of almost $1.6 billion — the acquisition of Newstrike will increase the company’s distribution footprint from three to eight provinces, and potentially propel it to become one of the top four biggest cannabis companies in Canada, after Canopy Growth, Aurora, Aphria Inc. and Tilray Inc.

“We’re adding $55 million in cash to HEXO with this acquisition, and this is in line with our vision to be in the top 3 cannabis companies worldwide,” said Sebastien St. Louis, HEXO’s Chief Executive Officer.

“We started conversations last October, and it was a relatively quick process because our visions were aligned. We’re excited about Newstrike’s agreement with the Neal Brothers to create specialty products for the edibles market and so that joint venture will be integrated into this acquisition,” St. Louis explained.

Canada embarks on its second phase of legalization in a matter of months — cannabis edibles, beverages and concentrates are set to hit the recreational market this October.

HEXO’s revenues come largely from the Quebec recreational cannabis market — for its latest quarter ending Oct. 31, 2018, the company brought in a net revenue of $3.7 million, and shipped 952 kilograms of dried flower equivalents to the adult-use market, most of which went to fulfill its supply agreement with Quebec’s provincial distributor. The company sits on a 1 million square-foot greenhouse in Gatineau, Que. which yields over 14 tonnes of cannabis annually, according to corporate disclosures.

Newstrike currently has two cannabis facilities in Ontario — an indoor grow room in Brantford, and a greenhouse in Niagara. Both facilities are licensed to cultivate and sell cannabis for the recreational market under the UP Cannabis brand. Newstrike’s most recent quarterly report ending Sept. 30, 2018 showed that the company realized a revenue of just over $3.4 million to the adult-use market.

“We’ve always recognized that to become a dominant player in the Canadian cannabis sector we needed a strong partner,” said Newstrike CEO Jay Wilgar. “You look at our partnership with the Hip, with the Neal Brothers and then you look at HEXO’s partnership with Molson Coors… putting these two companies together makes an enormous amount of sense.”

Tragically Hip members Johnny Fay, Paul Langlois and Rob Baker (left to right) at Newstrike’s Up Cannabis grow room in Brantford, Ontario.Courtesy of David Bastedo

HEXO is one of very few pot firms that have struck coveted deals with alcohol, tobacco and pharmaceutical companies over the last six months — Cronos Group announced a $2.4 billion investment from tobacco giant Altria Group last December, while Tilray Inc. partnered up with Swiss drug giant Novartis AG around the same time to develop and distribute medical cannabis.

Both Wilgar and St. Louis are confident that the merger of both companies will generate a combined revenue of $400 million by mid-2020.

“Everytime we have committed something to the market, we have delivered. We announced that by December 2018 we would have 1 million square foot up and running, and we met that promise and we got all our licenses in under a year,” St. Louis said.

Wilgar declined to elaborate on what his specific role would be post-acquisition, but maintained that he would continue to be actively involved in Newstrike.

HEXO’s stock price closed at $7.40 Tuesday evening, while Newstrike’s hovered at the $0.45 mark. The Quebec company’s acquisition of Newstrike is the second big transaction to take place between cannabis companies post-legalization — in December, Aleafia Health Inc. acquired medical cannabis producer Emblem Corp. for $173 million.

    Related Posts:

    • No Related Posts